SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

Home・Akcijų sąrašas・Vetoquinol SA

Vetoquinol SA

Uždarymo kaina

SektoriusSveikatos priežiūra

71.4 0.99

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

69.3

Max

72.2

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-9.8M 25M
Pardavimai	-17M 258M
P/E Sektoriaus vid.	13.902 106.172
Dividendų pajamingumas	1.23
Pelno marža	9.734
Darbuotojai	2,497
EBITDA	-12M 48M

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	1.23% 2.31%

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-71M 839M
Ankstesnė atidarymo kaina	70.41
Ankstesnė uždarymo kaina	71.4

Naujienos nuotaikos

By Acuity

50%

177 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

72.6 / 75.1 Palaikymas ir pasipriešinimas

Vetoquinol SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-19 23:36; UTC

Karštos akcijos

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

2025-11-19 22:13; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

2025-11-19 21:55; UTC

Pagrindinės rinkos jėgos

Amgen Lung Cancer Drug Gets Full Approval From FDA

2025-11-19 21:43; UTC

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

2025-11-19 23:55; UTC

Rinkos pokalbiai

Gold Rises on Possible Investment Demand -- Market Talk

2025-11-19 23:54; UTC

Rinkos pokalbiai

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

2025-11-19 23:47; UTC

Uždarbis

Lenovo Group 2Q EPS $2.52 >0992.HK

2025-11-19 23:46; UTC

Uždarbis

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

2025-11-19 23:45; UTC

Uždarbis

Lenovo Group 2Q Rev $20.5B >0992.HK

2025-11-19 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

2025-11-19 23:42; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-11-19 23:41; UTC

Uždarbis

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

2025-11-19 23:41; UTC

Uždarbis

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

2025-11-19 23:40; UTC

Uždarbis

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

2025-11-19 22:55; UTC

Uždarbis

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

2025-11-19 22:41; UTC

Uždarbis

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

2025-11-19 22:30; UTC

Įsigijimai, susijungimai, perėmimai

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

2025-11-19 22:30; UTC

Uždarbis

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

2025-11-19 22:30; UTC

Įsigijimai, susijungimai, perėmimai

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

2025-11-19 22:27; UTC

Įsigijimai, susijungimai, perėmimai

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

2025-11-19 22:08; UTC

Uždarbis

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

2025-11-19 22:00; UTC

Uždarbis

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

2025-11-19 21:58; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

2025-11-19 21:52; UTC

Uždarbis

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

2025-11-19 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-11-19 21:49; UTC

Rinkos pokalbiai

Uždarbis

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

2025-11-19 21:38; UTC

Uždarbis

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

2025-11-19 21:28; UTC

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks to Buy Chronosphere for $3.35B

2025-11-19 21:27; UTC

Įsigijimai, susijungimai, perėmimai

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

2025-11-19 21:24; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Akcijų palyginimas

Kainos pokytis

Vetoquinol SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių Vetoquinol SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

72.6 / 75.1Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

177 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.